# Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas

> **NCT00624416** · PHASE1,PHASE2 · COMPLETED · sponsor: **Pennington Biomedical Research Center** · enrollment: 10 (actual)

## Conditions studied

- Lipoma

## Interventions

- **DRUG:** Prednisolone synthetic cortisone and Isoproterenol together

## Key facts

- **NCT ID:** NCT00624416
- **Lead sponsor:** Pennington Biomedical Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2015-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00624416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00624416, "Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00624416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*